Cwm, LLC Uni Qure N.V. Transaction History

Cwm, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$11.12 - $22.2 $366 - $732	33 Added 550.0%	39 $0
Q1 2023 Apr 28, 2023	SELL	$18.7 - $23.07 $1,196 - $1,476	-64 Reduced 91.43%	6 $0
Q4 2022 Feb 01, 2023	BUY	$18.12 - $27.32 $1,268 - $1,912	70 New	70 $2,000
Q1 2022 Apr 21, 2022	SELL	$14.54 - $21.5 $3,475 - $5,138	-239 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$20.24 - $36.01 $4,837 - $8,606	239 New	239 $5,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.